NYSE:MOH

Molina Healthcare Price Target, Predictions & Analyst Ratings

$282.74
+5.52 (+1.99 %)
(As of 09/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$276.27
$286.06
50-Day Range
$247.54
$279.33
52-Week Range
$151.66
$286.06
Volume233,049 shs
Average Volume314,509 shs
Market Capitalization$16.51 billion
P/E Ratio26.40
Dividend YieldN/A
Beta0.7

Molina Healthcare (NYSE:MOH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 15 Analyst Ratings

Analyst Price Target Consensus

$288.66

High PT$336.00
Average PT$288.66
Low PT$217.00
TypeCurrent
9/23/20 to 9/23/21
1 Month Ago
8/24/20 to 8/24/21
3 Months Ago
6/25/20 to 6/25/21
1 Year Ago
9/24/19 to 9/23/20
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
10 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$288.66$270.60$259.55$191.46
Price Target Upside2.09% Upside13.89% Upside14.07% Upside18.27% Upside
Get Molina Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MOH and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Molina Healthcare (NYSE:MOH) vs. Its Competitors

TypeMolina HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.60
2.73
2.56
Consensus RatingBuyBuyBuy
Price Target Upside124.31% Upside7.80% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
487
58.25%
Underperform Votes
349
41.75%
Avg. Outperform Votes
178
67.42%
Avg. Underperform Votes
86
32.58%
Avg. Outperform Votes
829
69.49%
Avg. Underperform Votes
364
30.51%

Molina Healthcare (NYSE:MOH) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/20/2021Morgan Stanley
Boost Price TargetOverweight$296.00 ➝ $316.00+13.61%
9/20/2021Truist Securities
Boost Price TargetBuy$300.00 ➝ $330.00+18.65%
9/20/2021Credit Suisse Group
Boost Price TargetOutperform$280.00 ➝ $318.00+14.33%
9/20/2021Stephens
Boost Price TargetEqual Weight$260.00 ➝ $280.00+0.67%
9/20/2021Mizuho
Boost Price TargetBuy$284.00 ➝ $305.00+9.66%
9/9/2021Cowen
Initiated CoverageOutperform$336.00+29.88%
8/3/2021Wells Fargo & Company
Boost Price TargetUnderweight$253.00 ➝ $256.00-6.65%
7/30/2021BMO Capital Markets
Matt Borsch
Boost Price TargetOutperform$300.00 ➝ $315.00+23.43%
7/9/2021Seaport Res Ptn
J. France
Reiterated RatingNeutral
7/9/2021Seaport Global Securities
Initiated CoverageNeutral$257.25+1.49%
2/19/2021Barclays
Reiterated RatingOverweight$260.00+20.31%
1/21/2021The Goldman Sachs Group
Initiated CoverageNeutral$217.00-2.53%
11/11/2020Piper Sandler
Boost Price TargetOverweight$213.00 ➝ $266.00+20.89%
10/30/2020SVB Leerink
D. Ha
Boost Price TargetOutperform$228.00 ➝ $255.00+36.28%
8/3/2020Deutsche Bank Aktiengesellschaft
Boost Price TargetBuy$188.00 ➝ $194.00+5.21%
6/1/2020SunTrust Banks
Boost Price TargetPositive ➝ Buy$210.00 ➝ $230.00+23.78%
5/4/2020Cfra
UpgradeHold ➝ Buy$141.00 ➝ $191.00+9.96%
4/8/2020Citigroup
UpgradeUnderperform ➝ Average$125.00 ➝ $171.00+22.05%
4/8/2020Bank of America
UpgradeUnderperform ➝ Buy$125.00 ➝ $171.00+22.05%
12/20/2019JPMorgan Chase & Co.
Boost Price TargetOverweight$150.00 ➝ $152.00+12.26%
10/30/2019Jefferies Financial Group
DowngradeBuy ➝ Hold$133.00 ➝ $120.00-3.75%
1/8/2019Mitsubishi UFJ Financial Group
J. Twizell
UpgradeNeutral ➝ Overweight
1/3/2019Wolfe Research
DowngradeOutperform ➝ Market Perform
10/9/2018Evercore ISI
Initiated CoverageIn-line ➝ In-Line$158.00+9.98%
9/26/2018Piper Jaffray Companies
Boost Price TargetOverweight$165.00+10.12%
(Data available from 9/23/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











Molina Healthcare (NYSE:MOH) Analyst Ratings Frequently Asked Questions

What is Molina Healthcare's consensus rating and price target?

According to the issued ratings of 15 analysts in the last year, the consensus rating for Molina Healthcare stock is Buy based on the current 1 sell rating, 4 hold ratings and 10 buy ratings for MOH. The average twelve-month price target for Molina Healthcare is $288.66 with a high price target of $336.00 and a low price target of $217.00. Learn more on MOH's analyst rating history

Do Wall Street analysts like Molina Healthcare more than its competitors?

Analysts like Molina Healthcare stock less than the stock of other Medical companies. The consensus rating score for Molina Healthcare is 2.60 while the average consensus rating score for medical companies is 2.73. Learn more on how MOH compares to other companies

Do MarketBeat users like Molina Healthcare more than its competitors?

MarketBeat users like Molina Healthcare stock less than the stock of other Medical companies. 58.25% of MarketBeat users gave Molina Healthcare an outperform vote while medical companies recieve an average of 67.42% outperform votes by MarketBeat users.

Does Molina Healthcare's stock price have much upside?

According to analysts, Molina Healthcare's stock has a predicted upside of 13.63% based on their 12-month price targets.

What analysts cover Molina Healthcare?

This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.